TrialBioMed research international2016

Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial.

Pavel Šponer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.